Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
Alpine Immune Sciences
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALPN-202
|
| gptkbp:indication |
solid tumors
hematologic malignancies |
| gptkbp:intendedUse |
immunotherapy
|
| gptkbp:mechanismOfAction |
CD28 costimulation
CTLA-4 blockade PD-L1 blockade |
| gptkbp:otherName |
davoceticept
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:CD28
gptkb:CTLA-4 PD-L1 |
| gptkbp:bfsParent |
gptkb:Alpine_Immune_Sciences,_Inc.
|
| gptkbp:bfsLayer |
7
|